Login / Signup

Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials.

Rish K PaiDavid E KleinerJohn HartOyedele A AdeyiAndrew D CloustonCynthia A BehlingDhanpat JainSanjay KakarMayur BrahmaniaLawrence BurgartKenneth P BattsMark A ValasekMichael S TorbensonMaha GuindiHanlin L WangVeeral AjmeraLeon A AdamsClaire E ParkerBrian G FeaganStephen CaldwellVipul Jairath
Published in: Alimentary pharmacology & therapeutics (2019)
The operating properties of the modifications proposed should be evaluated prospectively to determine reliability and responsiveness.
Keyphrases
  • clinical trial
  • liver fibrosis
  • phase ii
  • ultrasound guided
  • open label
  • double blind
  • phase iii
  • randomized controlled trial